MBRX (STOCKS)
Moleculin Biotech, Inc.
$2.697900
+0.057900 (+2.19%)
Prev close: $2.640000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Walter V. Klemp
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $14.61M
- Employees
- 17
- P/E (TTM)
- -0.10
- P/B (TTM)
- 0.93
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $27.03M |
| Research and Development | $17.83M |
| Other Operating Expenses | $9.20M |
| Operating Income/Loss | -$27.03M |
| Income/Loss From Continuing Operations After Tax | -$40.50M |
| Income/Loss From Continuing Operations Before Tax | -$40.50M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$40.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$40.50M |
| Net Income/Loss Available To Common Stockholders, Basic | -$42.37M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $1.87M |
| Preferred Stock Dividends And Other Adjustments | $1.87M |
| Basic Earnings Per Share | -$31.43 |
| Basic Average Shares | 37,312,611 |
| Assets | $23.36M |
| Current Assets | $10.96M |
| Noncurrent Assets | $12.40M |
| Fixed Assets | $70.00K |
| Other Non-current Assets | $12.33M |
| Liabilities | $8.18M |
| Current Liabilities | $7.96M |
| Accounts Payable | $4.57M |
| Wages | $2.17M |
| Other Current Liabilities | $1.22M |
| Noncurrent Liabilities | $218.00K |
| Equity | $15.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $15.18M |
| Liabilities And Equity | $23.36M |
| Net Cash Flow From Operating Activities | -$24.28M |
| Net Cash Flow From Operating Activities, Continuing | -$24.28M |
| Net Cash Flow From Investing Activities | -$2.60M |
| Net Cash Flow From Investing Activities, Continuing | -$2.62M |
| Net Cash Flow From Financing Activities | $26.90M |
| Net Cash Flow From Financing Activities, Continuing | $26.90M |
| Exchange Gains/Losses | -$14.00K |
| Net Cash Flow | $14.00K |
| Net Cash Flow, Continuing | $28.00K |
| Comprehensive Income/Loss | -$40.52M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$30.35M |
| Other Comprehensive Income/Loss | -$22.71M |